COMPASS PATHW SP.ADR Cash Flow Conversion Efficiency

Latest as of June 2026: -0.477x

COMPASS PATHW SP.ADR cash flow conversion efficiency. Based on the latest financial reports, COMPASS PATHW SP.ADR (5Y6) has a cash flow conversion efficiency ratio of -0.477x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-40.31 Million ≈ $-47.12 Million USD) by net assets (€84.53 Million ≈ $98.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of COMPASS PATHW SP.ADR (2021–2025)

Cash flow conversion efficiency of COMPASS PATHW SP.ADR from 2021 to 2025. This chart illustrates how COMPASS PATHW SP.ADR's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for COMPASS PATHW SP.ADR for real-time trading data and today's change.

COMPASS PATHW SP.ADR Cash Flow Conversion Ratio Explained

COMPASS PATHW SP.ADR cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

COMPASS PATHW SP.ADR Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of COMPASS PATHW SP.ADR ranked by their cash flow conversion efficiency. Also see COMPASS PATHW SP.ADR stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
China Union Holdings Ltd
SHE:000036
-0.005x
Great-Sun Foods Co Ltd
SHG:603336
0.091x
Grand Pacific Petrochemical Corp
TW:1312
0.073x
IRESS LTD
F:BRF
N/A
Liberty Broadband Srs A
NASDAQ:LBRDA
-0.012x
Biotest Aktiengesellschaft
XETRA:BIO3
-0.114x
Chapters Group AG
XETRA:CHG
0.040x
Zhejiang Yonggui Electric Equipment Co Ltd
SHE:300351
0.002x

Annual Cash Flow Conversion Efficiency for COMPASS PATHW SP.ADR (2021–2025)

The table below shows the annual cash flow conversion efficiency of COMPASS PATHW SP.ADR from 2021 to 2025. Review COMPASS PATHW SP.ADR (5Y6) financial flexibility to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €-52.85 Million
≈ $-61.78 Million
€-157.24 Million
≈ $-183.83 Million
2.975x +486.18%
2024-12-31 €154.69 Million
≈ $180.85 Million
€-119.19 Million
≈ $-139.34 Million
-0.770x -78.61%
2023-12-31 €225.74 Million
≈ $263.92 Million
€-97.38 Million
≈ $-113.84 Million
-0.431x +25.85%
2022-12-31 €181.28 Million
≈ $211.94 Million
€-105.45 Million
≈ $-123.28 Million
-0.582x -144.21%
2021-12-31 €284.41 Million
≈ $332.51 Million
€-67.75 Million
≈ $-79.20 Million
-0.238x --

About COMPASS PATHW SP.ADR

F:5Y6 Germany Medical Care Facilities
Market Cap
$841.91 Million
€720.13 Million EUR
Market Cap Rank
#10493 Global
#1253 in Germany
Share Price
€7.50
Change (1 day)
-3.23%
52-Week Range
€2.12 - €8.15
All Time High
€48.20
About

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as … Read more